SEC Form D · filed March 3, 2023
Voyager Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Michael W. Higgins · Cambridge, MADirectorTodd W. Carter · Dallas, TXExecRobin W. Swartz · Cambridge, MAExecAlfred Sandrock · CAMBRIDGE, MAExec · DirectorPeter Pfreundschuh · Cambridge, MAExecCatherine A. Mackey · Cambridge, MADirectorSteven A. Hyman · Cambridge, MADirectorJames A. Geraghty · Cambridge, MADirectorGrace A. Colon · Cambridge, MADirectorJude A. Onyia · Cambridge, MADirectorRobert W. Hesslein · Cambridge, MAExecGlenn A. Pierce · Cambridge, MADirectorNancy A. Vitale · Cambridge, MADirectorAlfred Sandrock · CAMBRIDGE, MAExec · DirectorPeter Pfreundschuh · Cambridge, MAExecCatherine A. Mackey · Cambridge, MADirectorMichael W. Higgins · CHICAGO, ILDirectorSteven A. Hyman · Cambridge, MADirectorJames A. Geraghty · LONDON, United KingdomDirectorGrace A. Colon · Cambridge, MADirectorJude A. Onyia · Cambridge, MADirectorRobert W. Hesslein · Cambridge, MAExecTodd W. Carter · Cambridge, MAExecGlenn A. Pierce · Cambridge, MADirectorRobin W. Swartz · Cambridge, MAExecNancy A. Vitale · Cambridge, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗